Abstract:The pathogenesis of Alzheimer's disease (AD) remains elusive. Brain glucose hypometabolism, an invariant feature, precedes and closely correlates with clinical symptoms and signs in AD. To clarify the mechanism of cerebral glucose metabolism will help to understand AD pathogenesis. Cerebral glucose metabolism was evaluated by FDG-PET in AD patients and the mice with thiamine deficiency (TD) by diet deprivation. Brain amyloid deposit was measured by PiB-PET. Thiamine diphosphate (TDP), thiamine monophosphate, and thiamine levels were detected by high performance liquid chromatography. The diagnostic value of blood TDP level for AD was analyzed. The effects of thiamine metabolism on dendrtic branching, spine, and soma size of enurons were investigated by inhibiting thiamine pyrophosphokinase (TPK), the key enzyme of thiamine metabolism, and transporters (SLC19A2, SLC19A3, SLC25A19) via TPK antagonist (pyrithiamine) and/or RNA interference. Blood TDP level in AD patients and blood and brain TDP levels in TD mice were significantly reduced as compared with that in control groups (n=1199 for human subjects and n=6 for mice), patients with vascular dementia (n=67) and frontotemporal dementia (n=13, all P<0.001). Blood TDP level in AD patients (n=14) and blood/brain TDP levels in TD mice (n=6) was closely correlated with glucose metabolism of cotices examined. Blood TDP level exhibited a promising value for AD diagnosis (0.830 of AUC, 76.5% of sensititvity, and 77.5% of specificity) and differential diagnosis from vascular dementia and frontotemporal dementia. Brain amyloid deposit in AD patients was not significantly correlated with blood TDP level (n=32). Pyrithiamine and RNA interference against TPK and transporters (SLC19A2, SLC19A3, SLC25A19) significantly reduced dendritic brainching, spine density, and soma size of neurons (n=9-64 in 3 batches of cultured hippocampal neurons). The disruption of thiamie metabolism in AD contributes to brain glucose hypometabolism and neurodegeneration. Combinging with the previous studies, we propose that AD is a metabolic disorder and hypothesize that disrutped thiamiine metabolism directly contributes to AD pathogenesis by perturbing glucose utilization and inducing multiple pathogenic factors in the brain. Altered thiamine metabolism is a useful diagnostic biomarker for AD and a potential target for the disease-modifying study.

Impaired Hippocampal Neurogenesis is Involved in Cognitive Dysfunction Induced by Thiamine Deficiency at Early Pre-Pathological Lesion Stage

Decreased Transketolase Activity Contributes to Impaired Hippocampal Neurogenesis Induced by Thiamine Deficiency.

Changes of Cognitive Function and Hippocampal Long-Term Potentiation in Adult Mice in Early Stage of Thiamine Deficiency

Effect of Thiamine Deficiency on Neurogenesis of Subventricular Zone in Mice

Thiamine Deficiency Causes Long-Lasting Neurobehavioral Deficits in Mice

Thiamine Deficiency Contributes to Synapse and Neural Circuit Defects

Decreased Activity of Transketolase is Related With Regionally Selective Damage of Brain Midline in Wernicke Encephalopathy

Downregulation of Transketolase Activity is Related to Inhibition of Hippocampal Progenitor Cell Proliferation Induced by Thiamine Deficiency.

Thiamine Deficiency Induced β-amyloid Deposition and Tau Hyperphosphorylation

P1‐078: Reduced Thiamine Diphosphate Level Contributes to Brain Glucose Hypometabolism and Neurodegeneration in Alzheimer's Disease

Thiamine Deficiency and Neurodegeneration: the Interplay Among Oxidative Stress, Endoplasmic Reticulum Stress, and Autophagy

Thiamine Deficiency Modulates p38MAPK and Heme Oxygenase-1 in Mouse Brain: Association with Early Tissue and Behavioral Changes

Thiamine Metabolism is Critical for Regulating Correlated Growth of Dendrite Arbors and Neuronal Somata.

The Protective Effects of Thiamine on Subventricular Zone Neurogenesis of MPTP-induced Parkinson's Disease Model in Adult Mice

Thiamine pyrophosphokinase-1 deficiency in neurons drives Alzheimer's multiple pathophysiological alterations

Exposure to Pyrithiamine Increases β-Amyloid Accumulation, Tau Hyperphosphorylation, and Glycogen Synthase Kinase-3 Activity in the Brain

Thiamine Diphosphate Reduction Strongly Correlates with Brain Glucose Hypometabolism in Alzheimer’s Disease, Whereas Amyloid Deposition Does Not

Stem Cell Therapy and Thiamine Deficiency-Induced Brain Damage

Thiamine deficiency induces endoplasmic reticulum stress and oxidative stress in human neurons derived from induced pluripotent stem cells

Low expression of thiamine pyrophosphokinase-1 contributes to brain susceptibility to thiamine deficiency

Impairment of Thiamine Transport at the GUT-BBB-AXIS Contributes to Wernicke's Encephalopathy